Good Post David.
C.R not to dilutive and very fair in one aspect that shareholder, can top up. I don’t like company that raise cash and don’t give investors (mums & dads) a fair go. Wayne has done a great job focusing AHZ down these product lines and this C.R will strengthen this commercial agenda.
More insto’s / sophisticated investors on the register are another positive.
Good leadership is VERY hard to find in a small cap bio / medteck stock and we have that, furthermore, world breaking products/s to match management in a space worth billions.
Too many people have slagged off over the past few days and if you cant sleep holding this stock then sell, but W.P decision to raise funds is the right move for the company and shareholders. The TRAV market is huge and ADAPTS technology is the best in the world so it makes sense to stay on top, and the 3D products take this technology to a new high. We need stay in front of competition. This C.R supports this and W.P has made the right move once again.
I look forward to applying for more stock at 30c and see far more upside now than in all the time I have held this stock.
From the annual report below, so it was no surprise to me they are raising funds!
All products are manufactured in and distributed from our state-of-the-art biomanufacturing facility in Perth, which has capacity to expand. ▪We have several as yet unannounced products in R&D.
BRDS Mike.
AHZ Price at posting:
31.5¢ Sentiment: Buy Disclosure: Held
(20min delay)